Healthcare -
Biotechnology - NASDAQ - US
$ 6.345
4.75 %
$ 513 M
Market Cap
-3.06
P/E
KURA - OTHER CURRENT LIABILITIES
Other Current Liabilities KURA - Kura Oncology, Inc.
68.8 M
LAST VALUE
96.13%
2 YEAR CAGR
42.93%
5 YEAR CAGR
57.05%
10 YEAR CAGR